Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection

Insights

Mouse cytomegalovirus (MCMV) infectivity for macrophages is enhanced by subneutralizing antibody concentrations, mediated by the Fc portion of IgG and macrophage Fc receptors. This phenomenon impacts MCMV virulence and macrophage interactions.

Area of Science:

  • Immunology
  • Virology

Background:

  • Mouse cytomegalovirus (MCMV) infectivity varies depending on its passage history.
  • Antibody interactions with viruses can modulate infectivity and pathogenicity.

Purpose of the Study:

  • To investigate the effect of antiviral antibodies on MCMV infectivity for macrophages.
  • To elucidate the mechanisms underlying antibody-mediated enhancement and neutralization of MCMV.

Main Methods:

  • In vitro studies using tissue culture-passed MCMV and resident mouse peritoneal macrophages.
  • Assays included fluorescent antibody staining and virus yield measurements.
  • Experiments utilized F(ab')2 fragments and Fc receptor blocking to dissect antibody-mediated effects.

Main Results:

  • Subneutralizing concentrations of anti-MCMV antibody enhanced MCMV infectivity for macrophages twofold.
  • Enhancement and neutralization at high antibody dilutions were dependent on the Fc portion of IgG and macrophage Fc receptors.
  • Coating MCMV with specific antibody concentrations altered its virulence in vivo.

Conclusions:

  • Antibody-dependent enhancement of MCMV infectivity is mediated by Fc-Fc receptor interactions.
  • The density of Fc on virus-immunoglobulin complexes influences macrophage interactions and viral pathogenicity.
  • Understanding these interactions is crucial for MCMV pathogenesis and therapeutic strategies.